Testotoxicosis without Testicular Mass: Revealed by Peripheral Precocious Puberty and Confirmed by Somatic LHCGR Gene Mutation

References

• Schedewie HK, Reiter EO, Beitins IZ, et al. Testicular leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab. 1981;52:271–278. doi:10.1210/jcem-52-2-271.
   PubMed Web of Science ®Google Scholar
• Shenker A, Laue L, Kosugi S, Merendino JJ Jr., Minegishi T, Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993;365:652–654. doi:10.1038/365652a0.
   PubMed Web of Science ®Google Scholar
• Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev. 2000;21:551–583. doi:10.1210/edrv.21.5.0409.
   PubMed Web of Science ®Google Scholar
• Reiter EO, Norjavaara E. Testotoxicosis: current viewpoint. Pediatr Endocrinol Rev. 2005;3:77–86.
   PubMedGoogle Scholar
• Reiter EO, Mauras N, McCormick K, et al. Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). J Pediatr Endocrinol Metab. 2010;23:999–1009. doi:10.1515/jpem.2010.161.
   PubMed Web of Science ®Google Scholar
• Kosugi S, Van Dop C, Geffner ME, et al. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet. 1995;4:183–188. doi:10.1093/hmg/4.2.183.
   PubMed Web of Science ®Google Scholar
• Gromoll J, Partsch CJ, Simoni M, et al. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab. 1998;83:476–480. doi:10.1210/jcem.83.2.4579.
   PubMed Web of Science ®Google Scholar
• Latronico AC, Abell AN, Arnhold IJ, et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 1998;83:2435–2440. doi:10.1210/jcem.83.7.4968.
   PubMed Web of Science ®Google Scholar
• Martin MM, Wu SM, Martin AL, Rennert OM, Chan WY. Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor. Eur J Endocrinol. 1998;139:101–106.
   PubMed Web of Science ®Google Scholar
• Muller J, Gondos B, Kosugi S, Mori T, Shenker A. Severe testotoxicosis phenotype associated with Asp578–>tyr mutation of the lutrophin/choriogonadotrophin receptor gene. J Med Genet. 1998;35:340–341. doi:10.1136/jmg.35.4.340.
   PubMed Web of Science ®Google Scholar
• Wu SM, Leschek EW, Brain C, Chan WY. A novel luteinizing hormone receptor mutation in a patient with familial male-limited precocious puberty: effect of the size of a critical amino acid on receptor activity. Mol Genet Metab. 1999;66:68–73. doi:10.1006/mgme.1998.2780.
   PubMed Web of Science ®Google Scholar
• Latronico AC, Shinozaki H, Guerra G Jr., et al. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix. J Clin Endocrinol Metab. 2000;85:4799–4805. doi:10.1210/jcem.85.12.7071.
   PubMed Web of Science ®Google Scholar
• Leschek EW, Chan WY, Diamond DA, et al. Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty. J Pediatr. 2001;138:949–951. doi:10.1067/mpd.2001.114477.
   PubMed Web of Science ®Google Scholar
• Nagasaki K, Katsumata N, Ogawa Y, Kikuchi T, Uchiyama M. Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/choriogonadotropin receptor in a Japanese boy with peripheral precocious puberty. Endocr J. 2010;57:1055–1060.
   PubMed Web of Science ®Google Scholar
• Ozcabi B, Tahmiscioglu Bucak F, Ceylaner S, et al. Testotoxicosis: report of two cases, one with a novel mutation in LHCGR gene. J Clin Res Pediatr Endocrinol. 2015;7:242–248. doi:10.4274/jcrpe.2067.
   PubMed Web of Science ®Google Scholar
• Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med. 1999;341:1731–1736. doi:10.1056/NEJM199912023412304.
   PubMed Web of Science ®Google Scholar
• Siviero-Miachon AA, Kizys MM, Ribeiro MM, Garcia FE, Spinola-Castro AM, Dias Da Silva MR. Cosegregation of a novel mutation in the sixth transmembrane segment of the luteinizing/choriogonadotropin hormone receptor with two Brazilian siblings with severe testotoxicosis. Endocr Res. 2017 May;42(2):117–124.
   PubMed Web of Science ®Google Scholar
• Richter-Unruh A, Jorch N, Wessels HT, Weber EA, Hauffa BP. Venous sampling can be crucial in identifying the testicular origin of idiopathic male luteinising hormone-independent sexual precocity. Eur J Pediatr. 2002;161:668–671. doi:10.1007/s00431-002-1094-6.
   PubMed Web of Science ®Google Scholar
• Sangkhathat S, Kanngurn S, Jaruratanasirikul S, et al. Peripheral precocious puberty in a male caused by Leydig cell adenoma harboring a somatic mutation of the LHR gene: report of a case. J Med Assoc Thai. 2010;93:1093–1097.
   PubMedGoogle Scholar
• Boot AM, Lumbroso S, Verhoef-Post M, et al. Mutation analysis of the LH receptor gene in Leydig cell adenoma and hyperplasia and functional and biochemical studies of activating mutations of the LH receptor gene. J Clin Endocrinol Metab. 2011;96:E1197–1205. doi:10.1210/jc.2010-3031.
   PubMed Web of Science ®Google Scholar
• Tanner J. Growth at Adolescence. Oxford: Blackwell Scientific Publications; 1962.
   Google Scholar
• Lumbroso S, Paris F, Sultan C. Activating gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome–a European collaborative study. J Clin Endocrinol Metab. 2004;89:2107–2113. doi:10.1210/jc.2003-031225.
   PubMed Web of Science ®Google Scholar
• Emerson RE, Ulbright TM. The use of immunohistochemistry in the differential diagnosis of tumors of the testis and paratestis. Semin Diagn Pathol. 2005;22:33–50.
   PubMed Web of Science ®Google Scholar
• Cocco S, Meloni A, Marini MG, Cao A, Moi P. A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male-limited precocious puberty. Hum Mutat. 1996;7:164–166. doi:10.1002/(SICI)1098-1004(1996)7:2<164::AID-HUMU13>3.0.CO;2-0.
   PubMed Web of Science ®Google Scholar
• Eyssette-Guerreau S, Pinto G, Sultan A, Le Merrer M, Sultan C, Polak M. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. J Pediatr Endocrinol Metab. 2008;21:995–1002. doi:10.1515/JPEM.2008.21.10.995.
   PubMed Web of Science ®Google Scholar
• Kawate N, Kletter GB, Wilson BE, Netzloff ML, Menon KM. Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). J Med Genet. 1995;32:553–554. doi:10.1136/jmg.32.7.553.
   PubMed Web of Science ®Google Scholar
• Kremer H, Mariman E, Otten BJ, et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet. 1993;2:1779–1783. doi:10.1093/hmg/2.11.1779.
   PubMed Web of Science ®Google Scholar
• Laue L, Chan WY, Hsueh AJ, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci U S A. 1995;92:1906–1910. doi:10.1073/pnas.92.6.1906.
   PubMed Web of Science ®Google Scholar
• Yano K, Hidaka A, Saji M, et al. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab. 1994;79:1818–1823. doi:10.1210/jcem.79.6.7527413.
   PubMed Web of Science ®Google Scholar
• Yano K, Saji M, Hidaka A, et al. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab. 1995;80:1162–1168. doi:10.1210/jcem.80.4.7714085.
   PubMed Web of Science ®Google Scholar
• Themmen AP. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction. 2005;130:263–274. doi:10.1530/rep.1.00663.
   PubMed Web of Science ®Google Scholar
• Teles M, Brito VN, Arnhold IJ, Mendonca BB, Latronico AC. Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor. J Pediatr Endocrinol Metab. 2006;19:541–544.
   PubMed Web of Science ®Google Scholar
• Boyce AM, Chong WH, Shawker TH, et al. Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab. 2012;97:E1782–1790. doi:10.1210/jc.2012-1791.
   PubMed Web of Science ®Google Scholar
• Rey RA, Venara M, Coutant R, et al. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Hum Mol Genet. 2006;15(24):3538–3543. doi:10.1093/hmg/ddl430.
   PubMed Web of Science ®Google Scholar
• Coutant LS, Rey R, Lahlou N, et al. Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab. 2001;86(4):1778–1781. doi:10.1210/jcem.86.4.7391.
   PubMed Web of Science ®Google Scholar
• Kreher NC, Pescovitz OH, Delameter P, Tiulpakov A, Hochberg Z. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr. 2006;149:416–420. doi:10.1016/j.jpeds.2006.04.027.
   PubMed Web of Science ®Google Scholar
• Babovic-Vuksanovic D, Donaldson MD, Gibson NA, Wallace AM. Hazards of ketoconazole therapy in testotoxicosis. Acta Paediatr. 1994;83:994–997.
   PubMed Web of Science ®Google Scholar
• Wit JM, Hero M, Nunez SB. Aromatase inhibitors in pediatrics. Nat Rev Endocrinol. 2011;8:135–147. doi:10.1038/nrendo.2011.161.
   PubMed Web of Science ®Google Scholar
• Lenz AM, Shulman D, Eugster EA, et al. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics. 2010;126:e728–733. doi:10.1542/peds.2010-0596.
   PubMed Web of Science ®Google Scholar
• Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85:3027–3035. doi:10.1210/jcem.85.9.6795.
   PubMed Web of Science ®Google Scholar